Rechercher dans ce blog

Monday, January 11, 2021

Moderna says COVID-19 vaccine immunity to stay at least a year - New York Post

Immunity from Moderna Inc’s COVID-19 vaccine should last at least a year, the company said on Monday at the J.P. Morgan Healthcare conference.

The drugmaker said it was confident that the messenger RNA (mRNA) technology it used was well suited to deploy a vaccine based on the new variant of the coronavirus which has emerged in a handful of countries.

The company’s vaccine, mRNA-1273, uses synthetic mRNA to mimic the surface of the coronavirus and teach the immune system to recognize and neutralize it.

Moderna said in December it would run tests to confirm the vaccine’s activity against any strain.

The company said on Monday it expects to deliver between 600 million doses and 1 billion does of its vaccine in 2021 and forecast vaccine-related sales of $11.7 billion for the year, based on advance purchase agreements signed with governments.

“The team feels very comfortable with the track record we have now … that we are on track to deliver at least 600 million doses,” Chief Executive Officer Stéphane Bancel said.

Let's block ads! (Why?)

Article From & Read More ( Moderna says COVID-19 vaccine immunity to stay at least a year - New York Post )
https://ift.tt/3qcitdf
Business

No comments:

Post a Comment

Search

Featured Post

Stocks making the biggest moves premarket: American Airlines, AutoZone, GlaxoSmithKline and others - CNBC

In this article VIR TSLA GSK-GB DBI AZO AAL Check out the companies making headlines before the bell: American A...

Postingan Populer